News | Balloon Catheter | February 24, 2020

Abbott Recalls Two Coronary Balloon Catheters That May Not Deflate

NC Trek RX and the NC Traveler coronary dilatation catheters part of FDA Class I recall 

NC Trek RX Coronary Dilatation Catheter is part of an FDA Class I recall because it may not defalte.

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — the NC Trek RX Coronary Dilatation Catheter and the NC Traveler Coronary Dilatation Catheter. The balloons from the impacted lots may not deflate as intended. The U.S. Food and Drug Administration (FDA) has classified this as a Class I recall. 

Potential risks of the balloons not deflating include prolonged cardiac ischemia, air embolism, thrombosis, myocardial infarction and additional intervention, such as surgery that could lead to post-operative complications, which include death.

The FDA has classified this as a Class I recall. The recalls includes balloon diameters 4 mm, 4.5 mm and 5 mm. The FDA said this recall does not affect patients who have successfully undergone cardiac procedures using these devices.

Abbott issued a field safety notice (FSN) Jan. 29, 2020, to physicians and hospitals who received coronary catheters from the affected lots. The company is arranging the return and replacement of all remaining products. The affected products were manufactured between July 29, 2019, through Dec. 19, 2019, and distributed between Aug. 16, 2019, and Jan. 3, 2020. The total number of distributed units from identified lots potentially affected is 40,429.

The frequency of reported events that include slow, partial and failure to deflate the balloon, is 0.12 percent worldwide. At the time the FSN was issued, there were no reports of patient death. Since the issuance of the FSN, Abbott has become aware of one reported case in which the inability to deflate the balloon necessitated intervention, which resulted in post-procedural complications leading to a patient death.

Healthcare providers that received the Jan. 29, 2020 FSN directed to read the document and follow its instructions.

 

 

Related Content

Edwards Lifesciences Recalls IntraClude Intra-aortic Occlusion Device
News | Balloon Catheter | July 15, 2019
Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during...
Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init